Search Results - "Quénet, F"

Refine Results
  1. 1

    Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases by Ychou, M., Viret, F., Kramar, A., Desseigne, F., Mitry, E., Guimbaud, R., Delpero, J. R., Rivoire, M., Quénet, F., Portier, G., Nordlinger, B.

    Published in Cancer chemotherapy and pharmacology (01-07-2008)
    “…Purpose To assess the rate of R 0 resection of liver metastases achieved after chemotherapy with FOLFIRINOX. Patients and methods Patients with histologically…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor? by Aubert, M., Mege, D., Goere, D., Ezzedine, W., Pocard, M., Quenet, F., Wernert, R., Glehen, O., Pirro, N.

    Published in European journal of surgical oncology (01-09-2024)
    “…Obesity is a public health concern with an increasing occurrence worldwide. Literature regarding impact of obesity on results after management of peritoneal…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients by Honoré, C., Delhorme, J.B., Nassif, E., Faron, M., Ferron, G., Bompas, E., Glehen, O., Italiano, A., Bertucci, F., Orbach, D., Pocard, M., Quenet, F., Blay, J.Y., Carrere, S., Chevreau, C., Mir, O., Le Cesne, A.

    Published in Surgical oncology (01-06-2019)
    “…Despite being associated with a very poor prognosis, long-term survivors across all series of Desmoplastic Small Round Cell Tumor (DSRCT) have been reported…”
    Get full text
    Journal Article
  11. 11

    Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer by Colombo, P.E, Labaki, M, Fabbro, M, Bertrand, M, Mourregot, A, Gutowski, M, Saint-Aubert, B, Quenet, F, Rouanet, P, Mollevi, C

    Published in Gynecologic oncology (01-11-2014)
    “…Abstract Objectives Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval debulking surgery (IDS) is the main objective of…”
    Get full text
    Journal Article
  12. 12

    Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy by Elias, D, Gilly, F, Quenet, F, Bereder, J.M, Sidéris, L, Mansvelt, B, Lorimier, G, Glehen, O

    Published in European journal of surgical oncology (01-05-2010)
    “…Abstract Objective To analyze a large series of patients with pseudomyxoma peritonei (PMP) treated with cytoreductive surgery associated with perioperative…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Non-medical caregivers and the use of intraperitoneal chemotherapy in the operating theatre: A survey on the perception of safety by Al Hosni, M., Rouget, C., Cusumano, C., Garcia Lozcano, E., Popescu, H., Carrere, S., Quénet, F., Sgarbura, O.

    Published in Journal of visceral surgery (01-12-2020)
    “…In the last two decades, intraperitoneal(IP) chemotherapy during surgery achieved recognition in the management of peritoneal metastases. Occupational hazard…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Management of colorectal peritoneal metastases: Expert opinion by Abboud, K., André, T., Brunel, M., Ducreux, M., Eveno, C., Glehen, O., Goéré, D., Gornet, J.-M., Lefevre, J.H., Mariani, P., Pinto, A., Quenet, F., Sgarbura, O., Ychou, M., Pocard, M.

    Published in Journal of visceral surgery (01-10-2019)
    “…When peritoneal metastases are diagnosed (strong agreement of experts): (i) seek advice from a multidisciplinary coordination meeting (MCM) with large…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups by Amblard, I., Mercier, F., Bartlett, D.L., Ahrendt, S.A., Lee, K.W., Zeh, H.J., Levine, E.A., Baratti, D., Deraco, M., Piso, P., Morris, D.L., Rau, B., Tentes, A.A.K., Tuech, J.-J., Quenet, F., Akaishi, E., Pocard, M., Yonemura, Y., Lorimier, G., Delroeux, D., Villeneuve, L., Glehen, O., Passot, G., Abba, J., Abboud, K., Alyami, M., Arvieux, C., Bakrin, N., Bereder, J.-M., Bouzard, D., Brigand, C., Carrère, S., Delroeux, D., Dumont, F., Eveno, C., Facy, O., Guyon, F., Kianmanesh, R., Lo Dico, R., Lorimier, G., Marchal, F., Mariani, P., Meeus, P., Msika, S., Ortega-Deballon, P., Paquette, B., Peyrat, P., Pirro, N., Pocard, M., Porcheron, J., Quenet, F., Rat, P., Sgarbura, O., Thibaudeau, E., Tuech, J.-J., Zinzindohoue, F., Ahrendt, S.A., Akaishi, E., Baik, S.H., Baratti, D., Bhatt, A., Cachin, P., Ceelen, W., De Hingh, I., De Simone, M., Dubé, P., Edwards, R.P., Franko, J., Gonzalez-Bayon, L., Gushchin, V., Holtzman, M.P., Hsieh, M.-C., Kecmanovic, D., Lee, K.W., Lehmann, K., Liu, Y., Mehta, S., Morris, D.L., O'Dwyer, S., Orsevigo, E., Pande, P.K., Park, E.J., Pingpank, J.F., Piso, P., Rajan, F., Rau, B., Sardi, A., Sideris, L., Sommariva, A., Spiliotis, J., Sugarbaker, P., Tentes, A.A.K., Teo, M., Yarema, R., Younan, R., Zaveri, S.S., Zeh, H.J.

    Published in European journal of surgical oncology (01-09-2018)
    “…Peritoneal metastasis from biliary carcinoma (PMC) is associated with poor prognosis when treated with chemotherapy. To evaluate the impact on survival of…”
    Get full text
    Journal Article
  20. 20